Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Nov;113(5):571-577.
doi: 10.1007/s00223-023-01135-7. Epub 2023 Sep 17.

Hepatitis C-associated Osteosclerosis (HCAO): Long-Term Follow-Up of a New Case Recovered After Antiviral Treatment

Gaetano Paride Arcidiacono  1 , Carlo Poci  2 , Stefania Sella  2 , Marco Onofrio Torres  2 , Francesca Zanchetta  2 , Alberta Cecchinato  2 , Martin Diogo  2 , Mor Peleg Falb  2 , Sandro Giannini  2
Affiliations
Case Reports

Hepatitis C-associated Osteosclerosis (HCAO): Long-Term Follow-Up of a New Case Recovered After Antiviral Treatment

Gaetano Paride Arcidiacono et al. Calcif Tissue Int. 2023 Nov.

Abstract

Hepatitis C-associated osteosclerosis (HCAO) is a very rare condition that can be observed in a small number of patients with Hepatitis C Virus (HCV) infection. HCAO is usually characterized by widespread bone sclerosis, associated with severe bone pain, and increased levels of bone turnover markers, especially alkaline phosphatase (ALP). In this report, we present the case of a 55-year-old woman who was affected by HCV and came to our attention for severe and diffuse bone pain. Radiological studies showed bone sclerosis, and bone mineral density (BMD) was markedly increased, as well as serum ALP levels. The patient was initially treated with intravenous pamidronate, which provided only a transient benefit on clinical symptoms. Then antiviral therapy for HCV (interferon-alfa and ribavirin) was started and it was effective in making the viral load undetectable. After a long follow-up period, we observed a persistent remission of bone pain, a reduction in BMD together with a progressive trend toward the normalization of bone turnover markers. In conclusion, HCAO, although rare, should be considered among the potential causes of increased bone mass in patients with HCV infection, and treatment for the underlying infection may be effective in controlling the manifestations of this disease.

Keywords: HCAO; HCV; Hepatitis C virus; Osteosclerosis.

PubMed Disclaimer

References

    1. Whyte MP (2018) Sclerosing bone disorders. Primer on the metabolic bone diseases and disorders of mineral metabolism. Wiley, Hoboken, pp 823–838 - DOI
    1. Villareal DT, Murphy WA, Teitelbaum SL et al (1992) Painful diffuse osteosclerosis after intravenous drug abuse. Am J Med. https://doi.org/10.1016/0002-9343(92)90165-8 - DOI - PubMed
    1. Diamond T, Depczynski B (1996) Acquired osteosclerosis associated with intravenous drug use and hepatitis C infection. Bone. https://doi.org/10.1016/s8756-3282(96)00304-3 - DOI - PubMed
    1. Bergman D, Einhorn TI, Forster G (1996) Stone bone syndrome–diffuse sclerosis of bone: a newly described clinical disorder. EndocrPract. https://doi.org/10.4158/EP.2.4.296 - DOI
    1. Whyte MP, Teitelbaum SL, Reinus WR (1996) Doubling skeletal mass during adult life: the syndrome of diffuse osteosclerosis after intravenous drug abuse. J Bone Miner Res. https://doi.org/10.1002/jbmr.5650110417] - DOI - PubMed

Publication types

Substances

LinkOut - more resources